Indeed, subjects with FLT3ITD had both decreased likelihood of achieving CR, and increased risk of relapse-related mortality across all AML classes, not just NPM1 (Supplementary Figs. 35, 36). Here, NPM1 is linked to acute myeloid leukemia.